BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12107672)

  • 1. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
    Pelz RK; Lipsett PA; Swoboda SM; Diener-West M; Powe NR; Brower RG; Perl TM; Hammond JM; Hendrix CW
    Intensive Care Med; 2002 Jun; 28(6):692-7. PubMed ID: 12107672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.
    McNeil SA; Malani PN; Chenoweth CE; Fontana RJ; Magee JC; Punch JD; Mackin ML; Kauffman CA
    Clin Infect Dis; 2006 Jan; 42(2):195-203. PubMed ID: 16355329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.
    Jung E; Byun S; Lee H; Moon SY; Lee H
    Am J Infect Control; 2014 Oct; 42(10):1062-6. PubMed ID: 25278394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
    Martínez JA; Ruthazer R; Hansjosten K; Barefoot L; Snydman DR
    Arch Intern Med; 2003 Sep; 163(16):1905-12. PubMed ID: 12963563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
    Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
    Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit.
    Peta M; Carretto E; Barbarini D; Zamperoni A; Carnevale L; Perversi L; Pagani M; Bonora MG; Fontana R; Marone P; Langer M
    Clin Microbiol Infect; 2006 Feb; 12(2):163-9. PubMed ID: 16441455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
    Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
    Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
    Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
    Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
    BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit.
    Puzniak LA; Mayfield J; Leet T; Kollef M; Mundy LM
    Clin Infect Dis; 2001 Jul; 33(2):151-7. PubMed ID: 11418873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of intensive care unit-acquired bloodstream infections.
    Laupland KB; Lee H; Gregson DB; Manns BJ
    J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay.
    Lloyd-Smith P; Younger J; Lloyd-Smith E; Green H; Leung V; Romney MG
    J Hosp Infect; 2013 Sep; 85(1):54-9. PubMed ID: 23920443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.
    Gearhart M; Martin J; Rudich S; Thomas M; Wetzel D; Solomkin J; Hanaway MJ; Aranda-Michel J; Weber F; Trumball L; Bass M; Zavala E; Steve Woodle E; Buell JF
    Clin Transplant; 2005 Dec; 19(6):711-6. PubMed ID: 16313314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections.
    Joels CS; Matthews BD; Sigmon LB; Hasan R; Lohr CE; Kercher KW; Norton J; Sing RF; Heniford BT
    Am Surg; 2003 Jun; 69(6):514-9. PubMed ID: 12852510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
    Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
    Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
    J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.